BeStock  

Absci Corp ABSI

US equityMarket cap rank #2985AI medical concept stocks
$7.51 −$0.65 (-7.97%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $7.61 +1.33%
Open$7.91
Prev close$8.16
Day range$7.44 – $8.14
Volume4.75M
Market cap$1.30B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership96.9%+2.11 pts vs. prior quarter
Institutions holding249+15 vs. prior quarter
Insider trades (recent)30 buys / 20 sellsNet buying
ARK fund activity-559,009 sh2 recent transactions · last 10 Nov 2026
Short interest20.88% of floatDays to cover 9.1 · as of 30 Oct 2026
Short-sale volume share22.8%5-day average of daily volume

Short-sale volume as % of daily volume

10%19%28%37%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$360.9K (9 inflow days, 11 outflow days).

Net flow by order size, last 20 sessions

+$1.1MSuper−$724.5KBig+$1.2MMid+$7.9MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 38.8% of shares outstanding.

Largest holders

  • FMR15.00%
  • BlackRock7.81%
  • ARK Investment Management LLC6.95%
  • State Street Global Advisors4.93%
  • Vanguard Capital Management, LLC4.10%
  • Columbia Management Investment Advisers, LLC4.07%
  • Sean McClain3.97%
  • Redmile Group, LLC3.93%

By investor type

  • Mutual Fund62.27%
  • Hedge Fund22.35%
  • VC/PE Fund7.93%
  • Individual/Insider4.66%
  • Public Company2.76%
  • Insurance Company0.79%
  • Private Company0.49%
  • Family Office/Trust0.16%

Reported short interest has fallen from 21.80% to 20.88% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
First Trust Advisors L.P. Mutual Fund 2026/Q3 +670,669 0.4%
BlackRock Mutual Fund 2026/Q3 +1,221,008 7.8%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +919,836 4.1%
Renaissance Technologies Corp. Hedge Fund 2026/Q3 +547,551 0.3%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +542,942 1.1%
Federated Hermes, Inc. Mutual Fund 2026/Q3 +513,657 0.3%
Geode Capital Management, LLC Mutual Fund 2026/Q3 +465,059 2.3%
State Street Global Advisors Mutual Fund 2026/Q3 +363,281 4.9%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +1,331,387 0.8%
Adage Capital Management, L.P. Hedge Fund 2026/Q3 +5,704,820 3.3%
D. E. Shaw & Co., L.P. Hedge Fund 2026/Q3 +4,589,937 3.0%
Columbia Management Investment Advisers, LLC Mutual Fund 2026/Q3 +3,811,622 4.0%
FMR Mutual Fund 2026/Q3 +2,859,051 14.8%
Two Sigma Investments, LP Hedge Fund 2026/Q3 +2,594,720 3.2%
BVF Partners L.P. Hedge Fund 2026/Q3 +2,361,674 1.4%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
28 Oct 2026 Sean McClain Chief Executive Officer Sale to Issuer -79,860 $12.10 6,808,735
11 Oct 2026 Zachariah Jonasson Chief Business Officer & CFO Sale to Issuer -387 $10.16 257,181
11 Oct 2026 Sean McClain Chief Executive Officer Sale to Issuer -23,293 $10.16 6,688,595
11 Oct 2026 Todd Bedrick Chief Accounting Officer Sale to Issuer -22,325 $10.16 107,871
30 Aug 2026 Zachariah Jonasson Chief Business Officer & CFO Sale to Issuer -8,320 $8.71 254,441
29 Jun 2026 Mary Szela Independent Director Open Market Acquisition +12,900 $11.54 21,300
23 Jun 2026 Sean McClain Chief Executive Officer Sale to Issuer -59,896 $10.08 6,653,555
3 Jun 2026 Mary Szela Independent Director Other Acquisition +8,400 – 8,400
3 Jun 2026 Mary Szela Independent Director Other Derivative Acquisition +33,200 $7.34 33,200
3 Jun 2026 Karen McGinnis Lead Independent Director Other Acquisition +10,100 – 10,100
3 Jun 2026 Karen McGinnis Lead Independent Director Other Derivative Acquisition +39,800 $7.34 39,800
3 Jun 2026 François van Houten Independent Director Other Acquisition +10,100 – 10,100
3 Jun 2026 François van Houten Independent Director Other Derivative Acquisition +39,800 $7.34 39,800
3 Jun 2026 Daniel Rabinovitsj Independent Director Other Acquisition +10,100 – 10,100
3 Jun 2026 Daniel Rabinovitsj Independent Director Other Derivative Acquisition +39,800 $7.34 39,800
3 Jun 2026 Menelas Nicolas Pangalos Independent Director & Member of Scientific Advisory Board Other Acquisition +10,100 – 13,000
3 Jun 2026 Menelas Nicolas Pangalos Independent Director & Member of Scientific Advisory Board Other Derivative Acquisition +39,800 $7.34 39,800
3 Jun 2026 Joseph Sirosh Independent Director Other Acquisition +10,100 – 10,100
3 Jun 2026 Joseph Sirosh Independent Director Other Derivative Acquisition +39,800 $7.34 39,800
30 May 2026 Zachariah Jonasson Chief Business Officer & CFO Sale to Issuer -8,319 $6.75 241,927

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 35,838,218 20.9% 9.1
15 Oct 2026 37,016,055 21.6% 9.0
30 Sep 2026 37,442,385 21.8% 7.5
15 Sep 2026 37,255,325 21.7% 14.4
31 Aug 2026 36,788,063 21.4% 12.5
14 Aug 2026 37,417,586 21.8% 15.2

Discussion

No comments yet — be the first to weigh in on ABSI.

Sign in to join the discussion.

Scroll to Top